XOMA Royalty Corporation XOMA

Updated: 10 Aug 2026

NASDAQ | Royalty Company | Biotechnology royalties

No signal published yet

We already track XOMA Royalty and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow XOMA Royalty free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Royalty Company
Sector
Biotechnology royalties
We're already tracking XOMA Royalty Corporation — here are the latest events we've registered

Recent News

  • On July 14, 2026, XOMA Royalty Corporation announced the closing of its acquisition by Ligand Pharmaceuticals Incorporated for $39.00 per share in cash plus one Contingent Value Right per share. Following the transaction, trading of XOMA's common stock was suspended on the Nasdaq exchange.

What Firelda Watch includes for XOMA Royalty Corporation

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of XOMA Royalty Corporation will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Royalty Companies

More companies in this sector

Want to follow XOMA Royalty Corporation? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow XOMA Royalty free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

XOMA Royalty Corporation XOMA
XOMA Royalty — follow and we'll monitor it
Follow XOMA Royalty free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.